Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Environ Monit Assess ; 185(2): 1265-72, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22527464

ABSTRACT

The World Health Organization has estimated that air pollution is responsible for 1.4 % of all deaths and 0.8 % of disability-adjusted life years. NOIDA, located at the National Capital Region, India, was declared as one of the critically air-polluted areas by the Central Pollution Control Board of the Government of India. Studies on the relationship of reduction in lung functions of residents living in areas with higher concentrations of particulate matter (PM) in ambient air were inconclusive since the subjects of most of the studies are hospital admission cases. Very few studies, including one from India, have shown the relationship of PM concentration and its effects of lung functions in the same location. Hence, a cross-sectional study was undertaken to study the effect of particulate matter concentration in ambient air on the lung functions of residents living in a critically air-polluted area in India. PM concentrations in ambient air (PM(1,) PM(2.5)) were monitored at residential locations and identified locations with higher (NOIDA) and lower concentrations (Gurgaon). Lung function tests (FEV(1), PEFR) were conducted using a spirometer in 757 residents. Both air monitoring and lung function tests were conducted on the same day. Significant negative linear relationship exists between higher concentrations of PM(1) with reduced FEV(1) and increased concentrations of PM(2.5) with reduced PEFR and FEV(1). The study shows that reductions in lung functions (PEFR and FEV(1)) can be attributed to higher particulate matter concentrations in ambient air. Decline in airflow obstruction in subjects exposed to high PM concentrations can be attributed to the fibrogenic response and associated airway wall remodeling. The study suggests the intervention of policy makers and stake holders to take necessary steps to reduce the emissions of PM concentrations, especially PM(1,) PM(2.5), which can lead to serious respiratory health concerns in residents.


Subject(s)
Air Pollutants/analysis , Air Pollution/statistics & numerical data , Inhalation Exposure/analysis , Particulate Matter/analysis , Adolescent , Adult , Female , Humans , India/epidemiology , Inhalation Exposure/statistics & numerical data , Male , Middle Aged , Respiratory Function Tests , Respiratory Tract Diseases/epidemiology , Risk Assessment , Young Adult
2.
Occup Med (Lond) ; 61(7): 512-4, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21685404

ABSTRACT

BACKGROUND: Pesticide sprayers in North India use different application methods for different crops. AIMS: To compare cholinesterase activity and symptoms in knapsack and tractor-mounted pesticide sprayers. METHODS: Blood cholinesterase activity and symptoms were recorded for 42 knapsack and 66 tractor-mounted sprayers attending a health camp in North India in 2009 and for 30 controls. RESULTS: One hundred and eight of 197 (55%) eligible sprayers consented to participate. Mean acetylcholinesterase (AChE) and butyrylcholinesterase activity was 33 and 60% lower, respectively, in knapsack sprayers than in controls (P < 0.001) and 56 and 62% lower, respectively, in tractor-mounted sprayers than in controls (P < 0.001). AChE depletion was greater in tractor-mounted sprayers than in knapsack sprayers (P < 0.001). In knapsack sprayers compared to controls, odds ratios (OR) were significantly raised for musculoskeletal symptoms (OR 3.9, 95% CI 1.03-18) but not for other symptoms. In tractor-mounted sprayers compared to controls, ORs were significantly raised for neurological (OR 7, 95% CI 2-23), ocular (OR 8.7, 95% CI 2.7-32), respiratory (OR 5.14, 95% CI 1-29), cardiovascular (OR 7.5, 95% CI 2-42), gastrointestinal (OR 5.43, 95% CI 2-18) and musculoskeletal (OR 6.12, 95% CI 2-26) symptoms but not for dermal symptoms (OR 1.93, 95% CI 0.3-20). CONCLUSIONS: The risk of cholinesterase inhibition and symptoms is greater in tractor-mounted than in knapsack pesticide sprayers and in both groups compared to controls. Occupational exposure in pesticide sprayers in North India needs better control, perhaps through redesign of spraying equipment.


Subject(s)
Acetylcholinesterase/blood , Agricultural Workers' Diseases/chemically induced , Butyrylcholinesterase/blood , Occupational Diseases/chemically induced , Occupational Exposure/adverse effects , Pesticides/toxicity , Adolescent , Adult , Agricultural Workers' Diseases/epidemiology , Female , Humans , India/epidemiology , Male , Middle Aged , Occupational Diseases/epidemiology , Odds Ratio , Risk , Young Adult
3.
Anim Reprod Sci ; 124(1-2): 61-4, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21392901

ABSTRACT

The objective of this study was to examine the follicular fluid biochemical and hormonal changes associated with ovarian follicular cysts in buffalo. Follicular fluid was aspirated from eight cysts and eight preovulatory follicles, and subjected to biochemical and hormonal analyses. Cysts were characterized by a greater (P<0.01) concentration of nitric oxide and lesser concentrations of ascorbic acid and glucose than that of preovulatory follicles (P<0.01 and P<0.05, respectively). Furthermore, follicular cysts had greater concentrations of progesterone (P<0.001), triiodothyronine (T(3)) and cortisol (P<0.05) and lesser concentrations of insulin (P<0.001) than preovulatory follicles. The results indicate follicular cysts in buffalo have an altered biochemical and hormonal composition. The alterations include increases in nitric oxide, progesterone, cortisol and T(3) concentrations with a concurrent reduction in ascorbic acid, insulin and glucose concentrations. The study suggests that greater progesterone concentrations possibly inhibit the onset of LH surge resulting in formation of follicular cysts in buffalo. In addition, it implies the plausible role of intra-ovarian regulators such as nitric oxide, ascorbic acid and insulin in development of the condition.


Subject(s)
Buffaloes/metabolism , Follicular Cyst/veterinary , Follicular Fluid/chemistry , Animals , Ascorbic Acid/analysis , Female , Follicular Cyst/metabolism , Follicular Fluid/metabolism , Glucose/analysis , Hydrocortisone/analysis , Insulin/analysis , Nitric Oxide/analysis , Ovulation , Progesterone/analysis , Triiodothyronine/analysis
4.
Indian J Occup Environ Med ; 13(3): 121-6, 2009 Dec.
Article in English | MEDLINE | ID: mdl-20442829

ABSTRACT

BACKGROUND: Shop keepers dealing with pesticides are exposed to multiple pesticides that include organophosphates, organochlorines, carbamates, pyrethroids. Hence an exploratory health study was conducted on shopkeepers selling pesticides in urban areas of Lucknow and Barabanki District, Uttar Pradesh, India. MATERIALS AND METHODS: Detailed information regarding socio-economic status, family history, personal habits and work practices were recorded for 20 subjects and controls by the investigator on a pre-tested questionnaire. Clinical examination including neurological studies of the shopkeepers and control subjects was done. RESULTS: The study revealed significant slowing of motor nerve conduction velocity and low peak expiratory flow rate among shopkeepers as compared to control subjects. Prevalence of significantly higher gastro-intestinal problems was also observed among exposed subjects. Neurological, ocular, cardiovascular and musculo-skeletal symptoms were also found to be higher among shopkeepers. This was not statistically significant. Significantly higher relative risk for sickness related to systems viz., cardio-vasular, genito-urinary, respiratory, nervous and dermal was observed among exposed subjects compared to controls. CONCLUSIONS: These findings provide a prima facie evidence of clinical manifestations because of multiple exposures to pesticides and poor safety culture at work place.

5.
Leukemia ; 16(11): 2285-91, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12399974

ABSTRACT

PTPases are key signaling molecules and targets for developing novel therapeutics. We have studied the in vitro biological activity of PTPase inhibitor sodium stibogluconate (SS) on differentiation and proliferation of myeloid leukemia cell lines (NB4, HL-60 and U937). SS (250 microg/ml, 6 days) induced 87% of NB4 cells to reduce nitroblue tetrazolium (NBT), in comparison to the 90% induced by ATRA (1 microM, 6 days). SS treatment of NB4 cells resulted in an increase of CD11b expression and of a morphologically more mature population, coincident with growth arrest at S phase and increased cell death. The effect of SS on NB4 differentiation was irreversible and required continuous drug exposure. SS (400 microg/ml, 6 days) induced 60% and 55% of NBT-positive cells in HL-60 and U937 cell lines, which were augmented in the presence of GM-CSF (25 ng/ml) to levels (85% and 81%, respectively) comparable to those induced by ATRA. SS induced increased tyrosine phosphorylation of cellular proteins in the AML cell lines and inactivated SHP-1 PTPase in NB4 cells, consistent with SS functioning as a PTPase inhibitor in the leukemia cells. These results provide the first evidence of an anti-leukemia activity of SS as a PTPase inhibitor.


Subject(s)
Antimony Sodium Gluconate/pharmacology , Antineoplastic Agents/pharmacology , Antiprotozoal Agents/pharmacology , Cell Cycle/drug effects , Cell Differentiation/drug effects , Leukemia, Myeloid/pathology , Acute Disease , Cell Division/drug effects , Gene Expression Regulation, Leukemic/drug effects , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Humans , Intracellular Signaling Peptides and Proteins , Leukemia, Myeloid/metabolism , Nitroblue Tetrazolium , Oxidation-Reduction , Phosphorylation/drug effects , Protein Tyrosine Phosphatase, Non-Receptor Type 6 , Protein Tyrosine Phosphatases/immunology , Protein Tyrosine Phosphatases/metabolism , Tretinoin/pharmacology , Tumor Cells, Cultured/drug effects , Tyrosine/metabolism
6.
J Immunol ; 167(6): 3391-7, 2001 Sep 15.
Article in English | MEDLINE | ID: mdl-11544330

ABSTRACT

Using in vitro protein tyrosine phosphatase (PTPase) assays, we found that sodium stibogluconate, a drug used in treatment of leishmaniasis, is a potent inhibitor of PTPases Src homology PTPase1 (SHP-1), SHP-2, and PTP1B but not the dual-specificity phosphatase mitogen-activated protein kinase phosphatase 1. Sodium stibogluconate inhibited 99% of SHP-1 activity at 10 micrograms/ml, a therapeutic concentration of the drug for leishmaniasis. Similar degrees of inhibition of SHP-2 and PTP1B required 100 micrograms/ml sodium stibogluconate, demonstrating differential sensitivities of PTPases to the inhibitor. The drug appeared to target the SHP-1 domain because it showed similar in vitro inhibition of SHP-1 and a mutant protein containing the SHP-1 PTPase domain alone. Moreover, it forms a stable complex with the PTPase: in vitro inhibition of SHP-1 by the drug was not removed by a washing process effective in relieving the inhibition of SHP-1 by the reversible inhibitor suramin. The inhibition of cellular PTPases by the drug was suggested by its rapid induction of tyrosine phosphorylation of cellular proteins in Baf3 cells and its augmentation of IL-3-induced Janus family kinase 2/Stat5 tyrosine phosphorylation and proliferation of Baf3 cells. The augmentation of the opposite effects of GM-CSF and IFN-alpha on TF-1 cell growth by the drug indicated its broad activities in the signaling of various cytokines. These data represent the first evidence that sodium stibogluconate inhibits PTPases and augments cytokine responses. Our results provide novel insights into the pharmacological effects of the drug and suggest potential new therapeutic applications.


Subject(s)
Antimony Sodium Gluconate/pharmacology , Cell Cycle Proteins , Cytokines/biosynthesis , Enzyme Inhibitors/pharmacology , Hematopoietic Stem Cells/drug effects , Milk Proteins , Phosphoprotein Phosphatases , Protein Tyrosine Phosphatases/antagonists & inhibitors , Proto-Oncogene Proteins , Animals , Antimony Potassium Tartrate/pharmacology , Antimony Sodium Gluconate/pharmacokinetics , Antiprotozoal Agents/pharmacology , Catalytic Domain/drug effects , Cell Line , Cytokines/genetics , DNA-Binding Proteins/metabolism , Dual Specificity Phosphatase 1 , Enzyme Inhibitors/pharmacokinetics , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Hematopoietic Stem Cells/enzymology , Hematopoietic Stem Cells/metabolism , Immediate-Early Proteins/analysis , Interferon-alpha/pharmacology , Interleukin-3/pharmacology , Intracellular Signaling Peptides and Proteins , Janus Kinase 2 , Mice , Phosphorylation/drug effects , Prodrugs/pharmacokinetics , Prodrugs/pharmacology , Protein Phosphatase 1 , Protein Processing, Post-Translational/drug effects , Protein Tyrosine Phosphatase, Non-Receptor Type 1 , Protein Tyrosine Phosphatase, Non-Receptor Type 11 , Protein Tyrosine Phosphatase, Non-Receptor Type 6 , Protein Tyrosine Phosphatases/analysis , Protein-Tyrosine Kinases/metabolism , Recombinant Fusion Proteins/metabolism , STAT5 Transcription Factor , Signal Transduction/drug effects , Suramin/pharmacology , Trans-Activators/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...